Health Care/Hospital

Cedrus Group to Launch the First Foreign-owned Investment Asset Management Company in Hainan, China

HONG KONG, Sept. 29, 2020 /PRNewswire/ -- Cedrus Group ("Cedrus") , a global boutique investment group, is pleased to announce that it will launch thefirst foreign-owned investment asset management company inHainan province to better position the group to capi...

2020-09-29 09:00 5960

Large Study shows 230 Times Higher One Year Cancer Risk If Tumor Cell Clusters are Detected in Blood of Normal Individuals - Datar Cancer Genetics

MUMBAI, India and LONDON, Sept. 29, 2020 /PRNewswire/ -- A landmark study published in the American Association of Cancer Research's (AACR) prestigious journal 'Cancer Prevention Research' has shown that it is possible to identify healthy individuals with higher risk of cancer based on a simple b...

2020-09-29 07:00 2782

New Study: Postoperative Pain Can Be Reduced by Using NOL Monitoring to Guide Analgesic Medication During Surgery

RAMAT GAN, Israel, Sept. 29, 2020 /PRNewswire/ -- A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain. Exploring the potential use of NOL monitoring to help enhance recovery after surgery, t...

2020-09-29 06:30 2117

USANA Philippines named number one vitamins and dietary supplements brand by world-leading market research company

SALT LAKE CITY, Sept. 29, 2020 /PRNewswire/ -- To be named the number one company in your industry is a feat few have accomplished—but USANA Philippines has now earned this title two years running. USANA Philippines was recently recognized as the No. 1 Vitamins and Dietary Supplements Brand in...

2020-09-29 03:45 7501

New Guidelines for Maximizing Cures and Minimizing Side Effects in Children with Hodgkin Lymphoma

The National Comprehensive Cancer Network publishes free treatment recommendations for pediatric Hodgkin lymphoma, adding to growing library of pediatric cancer guidelines. PLYMOUTH MEETING, Pennsylvania, Sept. 28, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) toda...

2020-09-28 20:35 2243

Frost & Sullivan Reveals 9 Global Trends Generating Growth Opportunities from COVID-19

Automation/robotics, advanced data analytics, IoT & sensorization, security & privacy, and business model innovation are the five critical success factors for growth SANTA CLARA, Calif., Sept. 28, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,The Reshaping of Industries Caused by COVID...

2020-09-28 20:07 2824

Daewoong Pharmaceutical announces Korea's first-ever SGLT2 inhibitor for diabetes treatment

* Daewoong Pharmaceutical's enavogliflozin to demonstrate remarkable blood glucose lowering effect and favorable safety in type 2 diabetic patients through phase 2 clinical trial * Presented and demonstrated the result of phase 2 clinical trial in Korean patients with type 2 diabetes at the i...

2020-09-28 20:00 1953

World Heart Federation says perfect storm for heart disease created by COVID-19

GENEVA, Sept. 28, 2020 /PRNewswire/ -- COVID-19 is creating a perfect storm for heart health, the World Heart Federation (WHF) warns on World Heart Day. Three main factors are contributing to this. First, people with COVID-19 and heart disease are among those with the highest risk of death and se...

2020-09-28 19:05 3310

ILIAS Biologics Closes $20.6 Million Series B Financing

DAEJEON, South Korea, Sept. 28, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"), a leading exosome-based therapeutics company, announced today that the Company has completed a Series B financing round of$20.6 million inSouth Korea. The initial investors from the Series A rou...

2020-09-28 19:00 1716

World's first clinical trial of non-viral PD1 specific targeted CAR T therapy achieves great breakthroughs

SHANGHAI, Sept. 28, 2020 /PRNewswire/ -- On September 25, 2020, BIORAY LABORATORIES Inc. ("Bioraylab"), a company specialized in gene therapy and cell drug R&D, announced for the first time that clinical trials of non-viral PD1 specific targeted CAR T therapy in relapsed/refractory B-cell non-Hod...

2020-09-28 19:00 1593

Mumbai Municipal Commissioner I.S. Chahal Honoured With Global 'Covid Crusader Award-2020'

PUNE, India, Sept. 28, 2020 /PRNewswire/ -- Iqbal Singh Chahal, I.A.S., Municipal Commissioner of the Municipal Corporation ofGreater Mumbai, has become the first Indian bureaucrat to be recognised and receive global acknowledgment for his contribution in controlling the novel coronavirus infect...

2020-09-28 18:08 3346

Carmine Therapeutics named as one of FierceBiotech's "Fierce 15" Biotech Companies of 2020

CAMBRIDGE, Mass., Sept. 28, 2020 /PRNewswire/ -- Carmine Therapeutics announced today that it has been named by FierceBiotech as one of 2020's Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.  The 2020 Fierce 15 com...

2020-09-28 18:00 1439

Innovent Biologics Announces to Host 2020 Virtual R&D Day on November 10th

SAN FRANCISCO and SUZHOU, China, Sept. 28, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major d...

2020-09-28 12:13 5616

Qiming's Portfolio Company Zai Lab Lists on Main Board of HKEX

SHANGHAI, Sept. 28, 2020 /PRNewswire/ -- Qiming's portfolio company Zai Lab (SEHK:9688, NASDAQ:ZLAB), an innovative commercial-stage biopharmaceutical company, officially listed on the Main Board of The Stock Exchange of Hong Kong Limited today. In this secondary listing, the issue price is HK$5...

2020-09-28 11:26 5458

Yili and More Than 200 Business Leaders Pledge Support for Renewed Global Cooperation as the United Nations Turns 75

BEIJING, Sept. 28, 2020 /PRNewswire/ -- Companies from over 100 countries demonstrated their support for the Statement from Business Leaders for Renewed Global Cooperation presented to UN Secretary - GeneralAntonio Guterres by Sanda Ojiambo, the CEO & Executive Director of the UN Global Compact o...

2020-09-28 11:07 2140

MORS Group: Manulife Cambodia wins Top Workplaces in Asia award 2020

PHNOM PENH, Cambodia, Sept. 28, 2020 /PRNewswire/ -- Manulife Cambodia, the country's first international life insurer, recently received the title of "Top Workplaces inAsia" from the Asia Corporate Excellence & Sustainability Awards 2020, organized by MORS Group. This marks the company's second ...

2020-09-28 11:00 5649

TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Injection) ORIENT-32 Study Met Its Primary Endpoints of Progression-Free Survival and Overall Survival in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma (HCC)

SAN FRANCISCO and SUZHOU, China, Sept. 28, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major d...

2020-09-28 10:15 6287

Zymo Research Granted CE IVD Mark for Sample Collection Devices

IRVINE, California, Sept. 28, 2020 /PRNewswire/ -- Zymo Research announced that three of itsDNA/RNA Shield™ collection devices: 1) DNA/RNA Shield™ collection tube w/ swab, 2) DNA/RNA Shield™ Saliva/Sputum Collection Kit, and 3) DNA/RNA Shield™ Fecal Collection Tube are now CE IVD marked for in vi...

2020-09-28 07:00 3871

Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study

* New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced * Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat, in a gold-standar...

2020-09-28 06:00 2587

InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL Ventures

SHANGHAI, Sept. 28, 2020 /PRNewswire/ -- InventisBio, a clinical stage biotech company dedicated to the research and development of innovative small molecule drugs, announced the recent completion of a$147 million series D financing which has attracted participation of many top biopharmaceutical ...

2020-09-28 05:00 4284
1 ... 717718719720721722723 ... 848